Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adagio Therapeutics, Inc. (ADGI)

4   0.25 (6.67%) 08-07 23:42
Open: 3.71 Pre. Close: 3.75
High: 4.015 Low: 3.625
Volume: 722,011 Market Cap: 439(M)
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.8 - 3.81 3.81 - 3.83
Low: 3.55 - 3.57 3.57 - 3.58
Close: 3.72 - 3.75 3.75 - 3.78

Technical analysis

as of: 2022-08-05 4:19:56 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.27     One year: 6.16
Support: Support1: 3.71    Support2: 3.21
Resistance: Resistance1: 4.51    Resistance2: 5.27
Pivot: 3.89
Moving Average: MA(5): 3.65     MA(20): 3.92
MA(100): 3.45     MA(250): 14.63
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 37.7     %D(3): 25.3
RSI: RSI(14): 56.6
52-week: High: 78.81  Low: 2.41
Average Vol(K): 3-Month: 809 (K)  10-Days: 417 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ADGI ] has closed below upper band by 41.1%. Bollinger Bands are 0.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 30 Jul 2022
We're Keeping An Eye On Adagio Therapeutics' (NASDAQ:ADGI) Cash Burn Rate - Simply Wall St

Wed, 27 Jul 2022
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

Fri, 22 Jul 2022
Do Analysts Expect Adagio Therapeutics Inc (ADGI) Stock to Rise After It Is Up 34.95% in a Month? - InvestorsObserver

Tue, 05 Jul 2022
Adagio Therapeutics Names David Hering Permanent CEO >ADGI - MarketWatch

Wed, 30 Mar 2022
Why Is Adagio Therapeutics (ADGI) Stock Up Today? - InvestorPlace

Fri, 18 Mar 2022
Adagio Therapeutics, Inc. Announces 2022 Annual Meeting of Stockholders - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 110 (M)
Shares Float 48 (M)
% Held by Insiders 32.5 (%)
% Held by Institutions 67.1 (%)
Shares Short 4,040 (K)
Shares Short P.Month 4,690 (K)

Stock Financials

EPS -2.64
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.19
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -220 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -1.52
PEG Ratio 0
Price to Book value 0.95
Price to Sales 0
Price to Cash Flow -2

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.